Empirical Finance, LLC Catalent, Inc. Transaction History

Empirical Finance, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$42.56 - $59.82 $1,489 - $2,093	-35 Reduced 0.67%	5,199 $293,000
Q3 2023 Nov 02, 2023	BUY	$44.2 - $50.2 $25,149 - $28,563	569 Added 12.2%	5,234 $238,000
Q2 2023 Jul 27, 2023	BUY	$31.86 - $67.26 $21,282 - $44,929	668 Added 16.71%	4,665 $202,000
Q1 2023 Apr 05, 2023	BUY	$45.44 - $74.26 $181,623 - $296,817	3,997 New	3,997 $262,000
Q3 2022 Nov 04, 2022	BUY	$72.36 - $113.1 $52,678 - $82,336	728 Added 24.97%	3,644 $264,000
Q2 2022 Aug 01, 2022	BUY	$87.2 - $114.05 $18,660 - $24,406	214 Added 7.92%	2,916 $313,000
Q1 2022 Apr 21, 2022	BUY	$94.19 - $124.49 $33,437 - $44,193	355 Added 15.13%	2,702 $300,000
Q4 2021 Feb 04, 2022	BUY	$119.57 - $139.07 $98,645 - $114,732	825 Added 54.2%	2,347 $300,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $166,156 - $216,656	1,522 New	1,522 $203,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

Stay updated on Empirical Finance, LLC with notifications on news.